Informations techniques
Exploitant
Winthrop médicaments (Groupe Sanofi Aventis)
Présentation
DILRENE LP 300 mg, gélule à libération prolongée
B/ 28 - (Code CIP : 331 991-4)
eNq1mF1v2jAUhu/5FVHuSfhoRzoFqo21G1KrMVq0aTfIJIdiFuz02AbaXz+HUJVOjsoMvkLEyTnHPq8fv3J8uVlm3gpQUM66fjNo+B6whKeUPXT98f11PfIve7V4QVZk77VO0AiaLd9LMiJE1y9GgykQJoJftzdfQH8P6PdqXsynC0jkm/eUpFnwjYj5LcmLd7x4xWnqLUHOedr1cyW3T71YSNRV9NYc/4icJBCHuyf7o4vJ2f7zOCyCHRBVCcAbwh6MQWdoFTNRiMBkn0h44PhkDp1MWlHnQ6MRWaWgYgSCK0xgSOR8iHxFU0jNmUgmwCrJbJ3eAa4ykEUSY/BwkSyFVXCyIJsRPA7MRX/So325kfVmvdk5b0XtTtRunUcXVqlwb6nM4tGTCPMc00nrIjo/a0XhDMOUZrqLUNe/kpJnWFo2ashRksxRi6jovxWbozwIj+9KIaUiz8hTsBC57VIRJHoYUCPB3USKGdyjhlSm1+yf+ExlWfifVY93CHFUcUGoPldMVpDkemS7EH3OJGyqO2oHP7nZaZGCOF3YZ87M4B+qaUYTW75pAikQcjwaVOPNGRk+EwFjdIeGn5SlfC1Oj5z9FjuqPt9S0xg0n7Qb+iho2x/4v7WYKg6eK4U8h1CTiIpjADNgM34sWrQ+zaFe1OlGmFtLxBOSQYUpqlsiRyvyxcM507y7/VQOGIN+vbq31coPBfh0t/1rDE3T7n6X7ZDsgvNanO/VXu7h7nH7tQxygJc+0w7RTu9o5sxcylx8DMM5EXVB9BIGeosddiBcnmTqmrSvnXPn8Z3YgNIWlaB1VPq0PD4P753tHn3PJBxrfHff7wy2MYdEBUf0ocS5M+gOrk7P8VfX66zs4Ru0uEuzdahEUs5cmSU1NQP42JNDt5Zdo+bD99mMVty8VEozDstbn14tDosbn17tL72dCfo=
nYrFKPa0RVMQGgD6